Brief: Marinus Pharmaceuticals Says On August 17, The PTAB Granted Co's Petition Seeking Post-Grant Review Of Ovid Therapeutics'
21/08/2023 12:16
Aug 21 (Reuters) - Marinus Pharmaceuticals Inc MRNS.O :
* MARINUS PHARMACEUTICALS INC - ON AUGUST 17, THE PTAB
GRANTED
CO'S PETITION SEEKING POST-GRANT REVIEW OF OVID THERAPEUTICS'
U.S. PATENT NO. 11,395,817
Further company coverage: MRNS.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Ovid Therapeutics
See all newsOvid Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary
Ovid Therapeutics Q2 revenue beats estimates
Brief: Ovid Therapeutics Q2 EPS USD -0.08
Ovid Therapeutics Inc. expected to post a loss of 11 cents a share - Earnings Preview
Brief: Ovid Therapeutics Appoints Leading Physician-Scientist And Biotech Innovator Anna Greka, M.D., Ph.D., To Board Of Directors